$EMCURE reported a 16.6% YoY increase in revenue to ₹9,204 crore for FY26, supported by a 22.2% rise in international revenue. EBITDA grew 21.8% to ₹1,789 crore with margins expanding to 19.4%, while PAT increased 33.1% to ₹941 crore. Strategic acquisitions and in-licensing deals bolstered the portfolio. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.